Concepedia

Mammen P. Mammen

MP

Statistics

Publications

5

Citations

455

H-Index

5

Active since

2020

Affiliations

The Wistar Institute(Current)

Inovio Pharmaceuticals (United States)

Hospital of the University of Pennsylvania

Alliance for Multispecialty Research (United States)

Mammen P. Mammen is an author at The Wistar Institute specializing in deoxyribonucleic acid (dna) vaccine, immunology, and infectious diseases.

Publications per year

2020–2022

5

Publications

5

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

Pablo Tebas, ShuPing Yang, Jean Boyer et al. · EClinicalMedicine · 2020 · 282 citations · Full text

, , +17

SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial

Kimberly A. Kraynyak, Elliott Blackwood, Joseph Agnes et al. · The Journal of Infectious Diseases · 2022 · 61 citations · Full text

, , +17

INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · npj Vaccines · 2021 · 50 citations · Full text

, , +17

Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: a preliminary report of a randomized, blinded, placebo-controlled, Phase 2 clinical trial in adults at high risk of viral exposure

Mammen P. Mammen, Pablo Tebas, Joseph Agnes et al. · medRxiv · 2021 · 43 citations · Full text

, , +17

INO-4800 DNA Vaccine Induces Neutralizing Antibodies and T cell Activity Against Global SARS-CoV-2 Variants

Viviane M. Andrade, Aaron Christensen-Quick, Joseph Agnes et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 19 citations · Full text

, , +17

1–5 of 5